# Rosetta Capital

Rosetta Capital is a Venture Capital based in Haddenham, United Kingdom.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Haddenham, United Kingdom
- **Region:** Europe
- **Address:** Rectory House, Haddenham, HP17 8DA, United Kingdom
- **Founded:** 2001
- **Assets under management:** Undisclosed
- **Website:** rosettacapital.com
- **LinkedIn:** https://www.linkedin.com/company/rosetta-capital

## Regulatory record

- **CRD number:** 168176
- **SEC file number:** 802-80322
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/168176

## About

Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors. Its investment approach is global, building leading healthcare companies and groundbreaking technologies. The firm's primary focus is direct secondary transactions, offering adaptable liquidity solutions to investors and corporations. It has engaged in 50+ venture investments through direct secondary transactions over more than 20 years.

## Sectors

- Life Sciences
- MedTech
- Biotech
- Pharmaceuticals

## Offices

- London, United Kingdom

## People

- Jonathan Hepple — Team
- Ken MacLeod — Team
- Michael Forer — Team
- Matthew James — Team
- Donovan Leung — Team
- Melissa Riachi — Team

## Questions

### How does Rosetta source its deals?

The firm sources proprietary secondary opportunities from European and North American healthcare investors and corporates looking to divest part or all of an investment. This route makes each transaction bilateral and negotiated, rather than coming through a broad intermediary auction, though Rosetta does not disclose specific sourcing partnerships.

### Which sectors does Rosetta specifically target for investment?

The firm invests exclusively in the life sciences and medical device sectors. Its portfolio spans biologics, small-molecule therapeutics, drug delivery, specialty pharma and medtech, with disclosed names including Immunocore, Mission Therapeutics and JenaValve.

### Does Rosetta participate in fund commitments or only direct deals?

Rosetta's activity is centered on direct secondary transactions in individual companies, not on buying limited-partner fund interests. Public materials do not indicate any separate fund-of-funds or primary LP commitment program.

### Where is Rosetta Capital's presence outside the UK?

While its registered offices are in Oxford and London, the firm's investment horizon is global, with a stated track record of executing transactions across North America and Europe. No additional office locations are disclosed.

### What is Rosetta Capital's known posture on co-investing alongside external GPs?

The firm makes direct secondary purchases and joins follow-on rounds, placing it alongside existing co-investors and management teams. Rosetta does not market a separate co-investment program for external limited partners, operating instead as a principal investor through its own fund vehicles.

## Related profiles

- [Rose Tech Ventures](https://altss.com/profile/rose-tech-ventures)
- [Rosewall International](https://altss.com/profile/rosewall-international)

---

Last updated: 2026-08-11T15:07:57.118Z

Canonical page: https://altss.com/profile/rosetta-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology